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Background: Fractional exhaled nitric oxide (FeNO) is a simple tool that has an established role in the 
assessment of airway inflammation in athletes. Specifically, FeNO provides information concerning asthma 
phenotypes, aetiology of respiratory symptoms, response to anti-inflammatory agents, course of disease and 
adherence to medication. It is recognised that FeNO can be influenced by a variety of external factors (e.g. 
atopic status, exercise, respiratory tract infection), however, there remains limited research concerning the 
impact of dietary nitrate ingestion. The primary aim of this study was therefore to evaluate the effect of 
acute dietary nitrate supplementation on FeNO and resting pulmonary function parameters.  
Method: The study was conducted as a randomised double-blind placebo-controlled trial. Thirty male 
endurance trained athletes (age: 28 ± 6 yrs; BMI: 23 ± 2 kg.m-2) free from cardio-respiratory and metabolic 
disease, and stable at time of study entry (i.e. entirely asymptomatic without recent respiratory tract 
infection) attended the laboratory on two separate occasions. On arrival to the laboratory, athletes 
consumed either 140ml nitrate-rich beetroot juice (15.2 mmol nitrate) (NIT) or nitrate-depleted beetroot 
juice (0 mmol nitrate) (PLA). In accordance with international guidelines all athletes performed resting FeNO 
and forced spirometry (2.5hrs post ingestion). Airway inflammation was evaluated using established FeNO 
thresholds: (intermediate [≥25ppb] and high [>50ppb]). 
Results:  All athletes demonstrated normal baseline lung function (FEV1 % predicted >80%). A three-fold rise 
in resting FeNO was observed following NIT (median [IQR]): 32ppb [37] in comparison to PLA: 10ppb [12] 
(P<0.001). Twenty-two athletes (73%) presented with raised FeNO following NIT (intermediate: n = 13; high: 
n = 9) in comparison to four athletes (13%) following PLA (intermediate: n = 2; high: n = 2). Despite this, no 
difference was observed in any pulmonary function parameters between visits (P>0.05). 
Conclusion: Dietary nitrate ingestion should be considered when employing FeNO for the assessment of 
airway health in athletes. Our findings have implications concerning the decision to initiate or modify inhaler 
therapy. Further research is therefore required to determine the impact of chronic dietary nitrate ingestion 
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on pulmonary function and bronchoprovocation testing in athletes with pre-existing asthma and/or exercise-
induced bronchoconstriction.   
